Get Connected:


Latest News

FDA Grants Flurry of Approvals Last Week
FDA approves 7 drugs and a device in less than a week.
More local pharmacies may be able to participate in Medicare Part D under proposed changes.
The FDA recently approved a telehealth option that will allow providers to remotely program cochlear implants.
Direct-acting antivirals drugs show similar cure rates in co-infected patients as high as mono-infected patients.
Top news of the day from across the healthcare landscape.
Top articles of the week from The American Journal of Pharmacy Benefits.
Medicare sequester cuts could restrict access to care for seniors with cancer.
Approximately 46% of Americans have high blood pressure, according to revised guidelines.
View More >

From the Journals

Focusing on cost alone could diminish the vital service aspects behind successfully caring for a patient in a specialty pharmacy.
In a review of publicly reported diabetes quality measures for Medicaid fee-for-service, overall reporting was low and reports of outcomes measures were rarely available.
This study assessed the impact of initiating hyaluronic acid injections on pain management pharmacotherapies utilization patterns in patients with knee osteoarthritis.
Initiation of treatment with guideline-recommended medications within 60 days of fibromyalgia diagnosis was associated with immediate annual healthcare cost savings.
The findings of a retrospective study suggest that timing of heart failure (HF)-related pharmacotherapy following a HF-related encounter has potential implications on subsequent healthcare costs.
Many healthcare stakeholders are concerned that pharmacy benefit managers use perverse incentives that work against healthcare goals, such as improved outcomes and lower costs.
For patients with psoriasis and/or psoriatic arthritis, actual-to-expected dosing ratios and costs were lower for etanercept than for ustekinumab.
Upcoming Partner Events